News tagged with angiogenesis

Related topics: blood vessels

Researchers generate immunity against tumor vessel protein

Sometimes a full-on assault isn't the best approach when dealing with a powerful enemy. A more effective approach, in the long run, may be to target the support system replenishing the supplies that keep your foe strong and ...

Apr 25, 2014
popularity 5 / 5 (5) | comments 0

Some stem cells can trigger tumors

(Medical Xpress) -- Stem cells often used in reconstructive surgery following mastectomies and other cancer-removal treatments may pose a danger: Cornell biomedical scientists have discovered that these cells, ...

Jun 05, 2012
popularity 5 / 5 (1) | comments 0

Blood protein EPO involved in origin and spread of cancer

Researchers at the Swedish medical university Karolinska Institutet have demonstrated that a growth hormone, PDGF-BB, and the blood protein EPO are involved in the development of cancer tumours and that they combine to help ...

Dec 05, 2011
popularity not rated yet | comments 1 | with audio podcast

Protein inhibits tumor growth

Cleveland: A previously unknown variant of an extensively studied protein has been found to inhibit the growth of tumors and slow the development of new blood vessels necessary for cancers to metastasize, according to Cleveland ...

Jun 19, 2014
popularity 5 / 5 (2) | comments 0

Angiogenesis

Angiogenesis is the physiological process involving the growth of new blood vessels from pre-existing vessels. Though there has been some debate over terminology, vasculogenesis is the term used for spontaneous blood-vessel formation, and intussusception is the term for the formation of new blood vessels by the splitting of exisiting ones.

Angiogenesis is a normal and vital process in growth and development, as well as in wound healing and in granulation tissue. However, it is also a fundamental step in the transition of tumors from a dormant state to a malignant one, leading to the use of angiogenesis inhibitors. The identification of an angiogenic diffusible factor derived from tumors was made initially by Greenblatt and Shubik in 1968.

This text uses material from Wikipedia licensed under CC BY-SA